JAMA Cardiology Author Interviews cover image

Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy Among Patients 75 Years or Older

JAMA Cardiology Author Interviews

00:00

Greater Absolute Risk Reduction in Older Patients

Bach explains the notably larger absolute risk reduction in patients ≥75 versus younger groups over seven years.

Play episode from 03:58
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
 Get the app